Clinical trial
Presurgical Smoking Cessation Intervention for Cancer Patients: The Resolve Study
NCT00575718 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Presurgical Smoking Cessation Intervention for Cancer Patients: The Resolve Study
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 22, 2002
- Completion date
- September 18, 2027
- Enrollment
- 204 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
newly diagnosed cancer patients